AstraZeneca Escapes Nexium False Ad Suit
By Jessica Corso ( July 8, 2015, 6:52 PM EDT) -- The health care funds of six New York-based unions cannot pursue a class action accusing AstraZeneca Pharmaceuticals LP of running a deceptive marketing campaign for the heartburn drug Nexium after a Delaware state judge ruled Wednesday the unions couldn't prove they had been injured by the campaign....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.